Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine

Approximately 2 million new cancer cases are attributed to infectious agents each year worldwide. Vaccines for the hepatitis B virus (HBV), a risk factor of hepatocellular cancer, and human papillomavirus (HPV), a risk factor of cervical cancer, are considered major successes in clinical chemopreven...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkki: Horng-Jyh Tsai
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Elsevier 2015-04-01
Ráidu:Taiwanese Journal of Obstetrics & Gynecology
Fáttát:
Liŋkkat:http://www.sciencedirect.com/science/article/pii/S1028455915000212

Geahča maid